I9L-MC-JZCA - ClinicalTrials.gov - NCT03343613
I9L-MC-JZCA - ClinicalTrials.gov - NCT03343613
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a diagnosis of cancer (solid tumor) that has spread to other parts of the body
Participants must be willing to provide required, newly acquired tumor biopsies (doctor removes a small amount of tissue)
Participants must NOT
Participants must not have cancer that has spread to the brain
Participants must not have an HIV infection or hepatitis B or C
Participants must not have previously received an indoleamine- 2,3-dioxygenase (IDO) inhibitor
Participants must not have an active autoimmune disease or currently require immunosuppression of >10 milligrams of prednisone or equivalent per day
Participants must not have lung disease or inflammation of the lungs or a history of lung inflammation that required steroids
Trial Summary
Conditions the trial is for
Solid Tumor
What the trial is testing?
LY3381916, LY3300054
Could I receive a Placebo?
no
Enrollment Goal
290
Trial Dates
November 2017 - May 2020
Trial Phase
1
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a diagnosis of cancer (solid tumor) that has spread to other parts of the body
Participants must be willing to provide required, newly acquired tumor biopsies (doctor removes a small amount of tissue)
Participants must NOT
Participants must not have cancer that has spread to the brain
Participants must not have an HIV infection or hepatitis B or C
Participants must not have previously received an indoleamine- 2,3-dioxygenase (IDO) inhibitor
Participants must not have an active autoimmune disease or currently require immunosuppression of >10 milligrams of prednisone or equivalent per day
Participants must not have lung disease or inflammation of the lungs or a history of lung inflammation that required steroids
Trial Summary
Conditions the trial is for
Solid Tumor
What the trial is testing?
LY3381916, LY3300054
Could I receive a Placebo?
no
Enrollment Goal
290
Trial Dates
November 2017 - May 2020
Trial Phase
1
Trial Locations
Hide locations not currently recruiting